DurgicalDurgical
EN
Open the app

Mirtazapine !

An antidepressant that blocks alpha-2 receptors to release more norepinephrine and serotonin. Causes sleepiness and appetite gain; rarely, low white cells.

Updated 2026-11-01

  • Class: Atypical antidepressants
  • Receptor: Alpha-2A adrenergic receptor (also 5-HT2, 5-HT3 and H1 receptors)
  • ATC code: N06AX11

Mechanism of action

Mirtazapine blocks presynaptic alpha-2 adrenergic autoreceptors and heteroreceptors, which normally act as a brake on release, so noradrenergic and serotonergic neurons release more transmitter. It also blocks 5-HT2 and 5-HT3 receptors, which may limit some serotonergic side effects (nausea, sexual dysfunction), and strongly blocks H1 receptors (sleepiness, appetite).

  1. Mirtazapine blocks presynaptic alpha-2 receptors
  2. The brake is removed: more norepinephrine and serotonin are released
  3. 5-HT2 and 5-HT3 block limits nausea and sexual side effects
  4. H1 block causes sleepiness and more appetite

Pharmacokinetics

Absorption
By mouth, as tablets or orally disintegrating tablets
Metabolism
Extensive in the liver
Half-life
About 20 to 40 hours; longer in women and older adults

Indications

  • Major depressive disorder in adults

Adverse effects

Common

  • Somnolence
  • Increased appetite and weight gain
  • Dry mouth and constipation
  • Dizziness
  • Rise in cholesterol and triglycerides

Contraindications

  • MAO inhibitors, including linezolid and intravenous methylene blue, or within 14 days of stopping an MAOI
  • Hypersensitivity to mirtazapine

Key interactions

Alcohol, benzodiazepines and other sedatives
Additive sedation and impaired motor skills
MAO inhibitors and other serotonergic drugs
Serotonin syndrome
Drugs that prolong the QT interval
Additive risk of arrhythmia
Strong CYP3A inhibitors or inducers
Higher or lower mirtazapine levels

What is monitored

  • Signs of infection (fever, sore throat, mouth ulcers) with a white cell count if they appear
  • Weight and lipids
  • Mood and suicidal thoughts
  • Sodium in older adults

Administration and safety

  • Given by mouth, preferably in the evening at bedtime because of sleepiness
  • Orally disintegrating tablets dissolve on the tongue
  • Stopped gradually

Nursing care

  • Teach the person to report fever, sore throat or mouth ulcers promptly (possible agranulocytosis)
  • Track weight and appetite, and warn about drowsiness when driving
  • Avoid alcohol and other sedatives
  • Assess suicidal thoughts early in treatment and after dose changes

Pregnancy and breastfeeding

Long experience in pregnancy has not reliably shown a drug-related risk of major birth defects or miscarriage; untreated depression also carries risks.

Test yourself

Think of the answer, then tap the question to see it.

How does mirtazapine increase norepinephrine and serotonin release without blocking reuptake?

It blocks presynaptic alpha-2 autoreceptors and heteroreceptors, removing the negative feedback on release.

Which two side effects make mirtazapine useful for a depressed older adult with insomnia and weight loss?

Sedation and increased appetite with weight gain, mainly from H1 block.

A patient on mirtazapine has fever and sore throat. What test is needed and why?

A white cell count, because mirtazapine can rarely cause agranulocytosis; it is stopped if the count is low.

Add to my cards (3)

← Back to the class: Atypical antidepressants

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - MIRTAZAPINE tablet, film coated (DailyMed (U.S. National Library of Medicine), 2026); Mirtazapine: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2025); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.